BioSpace News Archive

Drug Development

Synergy Pharmaceuticals Reaches Halfway Mark For The First Pivotal Phase 3 Trial Of Plecanatide In Patients With Chronic Idiopathic Constipation

July 14, 2014
·
1 min read
Policy

FDA Office Of Drug Evaluation III Approves Salix Pharmaceuticals, Ltd.’s Request That The FDA Approve The RELISTOR® Subcutaneous Injection sNDA For The Treatment Of Opioid-Induced Constipation In Patients With Chronic Non-Cancer Pain

July 14, 2014
·
1 min read
Policy

Paragonix Technologies Inc., Announces Filing Of A 510(K) Pre-Market Notification With FDA For The Paragonix Sherpa Perfusion Cardiac Transport System

July 14, 2014
·
1 min read
Policy

Progenics Pharmaceuticals, Inc. Holds Conference Call This Morning On FDA Appeal Response Regarding Relistor® sNDA For Patients With Chronic Non-Cancer Pain

July 14, 2014
·
4 min read
Biotech Bay

Ultragenyx Pharmaceuticals Announces Closing Of Public Offering Of Common Stock And Exercise Of Underwriters’ Option To Purchase Additional Shares

July 14, 2014
·
3 min read
Business

DaVita HealthCare Partners Inc. Schedules 2nd Quarter 2014 Investor Conference Call

July 14, 2014
·
1 min read
Business

Hemispherx Biopharma And Bioclones, A Leading South African Biotechnology Company, Join Forces On Novel Therapeutic Cancer Vaccine

July 14, 2014
·
7 min read
Genetown

Genocea Biosciences Commences Public Offering Of Common Stock

July 14, 2014
·
1 min read
FDA

Titan Spine Receives FDA Clearance To Launch Endoskeleton® TL Device For Lateral Spinal Fusion

July 14, 2014
·
3 min read
Helix Biopharma Announces Completion Of Private Placement

July 14, 2014
·
4 min read